Clinical Trial Update: THISTLE - The HIV-HCV Silibinin Trial [Phase 2]

View source ↗

Summary

Update on a Phase 2 HIV and Hepatitis C trial evaluating silibinin (THISTLE) conducted by University of Zurich. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Silibinin (silibinin)

Snippet

Sponsor: University of Zurich | Conditions: HIV, Hepatitis C | Phase 2 | Status: COMPLETED